trihexyphenidyl has been researched along with Neurologic Voice Disorder in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, K | 1 |
| Noda, S | 1 |
| Umezaki, H | 1 |
| Tomoda, H | 1 |
| Shibasaki, H | 1 |
| Kuroda, Y | 1 |
| Shin, T | 1 |
2 other studies available for trihexyphenidyl and Neurologic Voice Disorder
| Article | Year |
|---|---|
[Parkinson's disease associated with trihexyphenidyl (THP) induced dysphonia plicae ventricularis].
Topics: Aged; Female; Humans; Movement Disorders; Parkinson Disease; Sulpiride; Tongue Diseases; Trihexyphen | 1988 |
Voice tremor: dysregulation of voluntary expiratory muscles.
Topics: Clonazepam; Diazepam; Double-Blind Method; Electromyography; Humans; Propranolol; Respiratory Muscle | 1987 |